Wells Fargo’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
38,101
+37,801
| +12,600% | +$242K | ﹤0.01% | 4273 |
|
|
2025
Q1 | $1.06K | Hold |
300
| – | – | ﹤0.01% | 5765 |
|
|
2024
Q4 | $1.13K | Hold |
300
| – | – | ﹤0.01% | 5743 |
|
|
2024
Q3 | $972 | Hold |
300
| – | – | ﹤0.01% | 5718 |
|
|
2024
Q2 | $570 | Sell |
300
-20,649
| -99% | -$39.2K | ﹤0.01% | 5753 |
|
|
2024
Q1 | $59.5K | Sell |
20,949
-13,316
| -39% | -$37.8K | ﹤0.01% | 4801 |
|
|
2023
Q4 | $504K | Sell |
34,265
-11,076
| -24% | -$163K | ﹤0.01% | 3517 |
|
|
2023
Q3 | $830K | Sell |
45,341
-12,154
| -21% | -$223K | ﹤0.01% | 3205 |
|
|
2023
Q2 | $1.24M | Buy |
57,495
+35,545
| +162% | +$767K | ﹤0.01% | 3126 |
|
|
2023
Q1 | $644K | Buy |
21,950
+20,231
| +1,177% | +$594K | ﹤0.01% | 3447 |
|
|
2022
Q4 | $63.5K | Buy |
1,719
+762
| +80% | +$28.2K | ﹤0.01% | 4455 |
|
|
2022
Q3 | $27K | Sell |
957
-621
| -39% | -$17.5K | ﹤0.01% | 4923 |
|
|
2022
Q2 | $30K | Sell |
1,578
-88,246
| -98% | -$1.68M | ﹤0.01% | 4983 |
|
|
2022
Q1 | $1.16M | Buy |
+89,824
| New | +$1.16M | ﹤0.01% | 3536 |
|